Insmed announces proposed $500 million public offering of common stock

Bridgewater, n.j. , may 28, 2024 /prnewswire/ -- insmed incorporated (nasdaq: insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it intends to offer and sell $500 million of shares of its common stock in an underwritten public offering.
INSM Ratings Summary
INSM Quant Ranking